These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8446427)

  • 1. Genetic defects in proteoglycan biosynthesis.
    Quentin-Hoffmann E; Harrach B; Robenek H; Kresse H
    Padiatr Padol; 1993; 28(1):37-41. PubMed ID: 8446427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genetic defect in the biosynthesis of dermatan sulfate proteoglycan: galactosyltransferase I deficiency in fibroblasts from a patient with a progeroid syndrome.
    Quentin E; Gladen A; Rodén L; Kresse H
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1342-6. PubMed ID: 2106134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycan profiling of a defect in decorin glycosylation in equine systemic proteoglycan accumulation, a potential model of progeroid form of Ehlers-Danlos syndrome.
    Kim B; Yoon JH; Zhang J; Eric Mueller PO; Halper J
    Arch Biochem Biophys; 2010 Sep; 501(2):221-31. PubMed ID: 20599673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers-Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I (beta4GalT-7).
    Seidler DG; Faiyaz-Ul-Haque M; Hansen U; Yip GW; Zaidi SH; Teebi AS; Kiesel L; Götte M
    J Mol Med (Berl); 2006 Jul; 84(7):583-94. PubMed ID: 16583246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective glycosaminoglycan substitution of decorin in a patient with progeroid syndrome is a direct consequence of two point mutations in the galactosyltransferase I (beta4GalT-7) gene.
    Götte M; Kresse H
    Biochem Genet; 2005 Feb; 43(1-2):65-77. PubMed ID: 15859521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of β1,4-galactosyltransferase 7 genetic mutations linked to the progeroid form of Ehlers-Danlos syndrome (EDS).
    Bui C; Talhaoui I; Chabel M; Mulliert G; Coughtrie MW; Ouzzine M; Fournel-Gigleux S
    FEBS Lett; 2010 Sep; 584(18):3962-8. PubMed ID: 20691685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in the Pathophysiology of Musculocontractural Ehlers-Danlos Syndrome.
    Kosho T; Mizumoto S; Watanabe T; Yoshizawa T; Miyake N; Yamada S
    Genes (Basel); 2019 Dec; 11(1):. PubMed ID: 31905796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in heparan sulfate are associated with delayed wound repair, altered cell migration, adhesion and contractility in the galactosyltransferase I (beta4GalT-7) deficient form of Ehlers-Danlos syndrome.
    Götte M; Spillmann D; Yip GW; Versteeg E; Echtermeyer FG; van Kuppevelt TH; Kiesel L
    Hum Mol Genet; 2008 Apr; 17(7):996-1009. PubMed ID: 18158310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic heterogeneity and clinical variability in musculocontractural Ehlers-Danlos syndrome caused by impaired dermatan sulfate biosynthesis.
    Syx D; Van Damme T; Symoens S; Maiburg MC; van de Laar I; Morton J; Suri M; Del Campo M; Hausser I; Hermanns-Lê T; De Paepe A; Malfait F
    Hum Mutat; 2015 May; 36(5):535-47. PubMed ID: 25703627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective initiation of glycosaminoglycan synthesis due to B3GALT6 mutations causes a pleiotropic Ehlers-Danlos-syndrome-like connective tissue disorder.
    Malfait F; Kariminejad A; Van Damme T; Gauche C; Syx D; Merhi-Soussi F; Gulberti S; Symoens S; Vanhauwaert S; Willaert A; Bozorgmehr B; Kariminejad MH; Ebrahimiadib N; Hausser I; Huysseune A; Fournel-Gigleux S; De Paepe A
    Am J Hum Genet; 2013 Jun; 92(6):935-45. PubMed ID: 23664118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ehlers-Danlos syndrome associated with glycosaminoglycan abnormalities.
    Miyake N; Kosho T; Matsumoto N
    Adv Exp Med Biol; 2014; 802():145-59. PubMed ID: 24443026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosaminoglycan alteration in the skin of children with classical Ehlers-Danlos syndrome.
    Yamakage A; Uchiyama Y; Nihei Y; Ishikawa H
    Acta Derm Venereol; 1985; 65(6):489-94. PubMed ID: 2420112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [XGalT-1 involved in the synthesis of glyosaminoglycans of proteoglycans and Ehlers-Danlos syndrome (progeroid type)].
    Furukawa K; Okajima T; Nakamura Y
    Tanpakushitsu Kakusan Koso; 2003 Jun; 48(8 Suppl):1152-7. PubMed ID: 12807023
    [No Abstract]   [Full Text] [Related]  

  • 14. Redefining the progeroid form of Ehlers-Danlos syndrome: report of the fourth patient with B4GALT7 deficiency and review of the literature.
    Guo MH; Stoler J; Lui J; Nilsson O; Bianchi DW; Hirschhorn JN; Dauber A
    Am J Med Genet A; 2013 Oct; 161A(10):2519-27. PubMed ID: 23956117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural alteration of glycosaminoglycan side chains and spatial disorganization of collagen networks in the skin of patients with mcEDS-CHST14.
    Hirose T; Takahashi N; Tangkawattana P; Minaguchi J; Mizumoto S; Yamada S; Miyake N; Hayashi S; Hatamochi A; Nakayama J; Yamaguchi T; Hashimoto A; Nomura Y; Takehana K; Kosho T; Watanabe T
    Biochim Biophys Acta Gen Subj; 2019 Mar; 1863(3):623-631. PubMed ID: 30553867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis for the progeroid variant of Ehlers-Danlos syndrome. Identification and characterization of two mutations in galactosyltransferase I gene.
    Okajima T; Fukumoto S; Furukawa K; Urano T
    J Biol Chem; 1999 Oct; 274(41):28841-4. PubMed ID: 10506123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in glycosaminoglycan biosynthesis associated with the Ehlers-Danlos syndromes.
    Syx D; Delbaere S; Bui C; De Clercq A; Larson G; Mizumoto S; Kosho T; Fournel-Gigleux S; Malfait F
    Am J Physiol Cell Physiol; 2022 Dec; 323(6):C1843-C1859. PubMed ID: 35993517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xylose phosphorylation functions as a molecular switch to regulate proteoglycan biosynthesis.
    Wen J; Xiao J; Rahdar M; Choudhury BP; Cui J; Taylor GS; Esko JD; Dixon JE
    Proc Natl Acad Sci U S A; 2014 Nov; 111(44):15723-8. PubMed ID: 25331875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosaminoglycan-free small proteoglycan core protein is secreted by fibroblasts from a patient with a syndrome resembling progeroid.
    Kresse H; Rosthøj S; Quentin E; Hollmann J; Glössl J; Okada S; Tønnesen T
    Am J Hum Genet; 1987 Sep; 41(3):436-53. PubMed ID: 3631078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of the core proteins of dermatan sulphate proteoglycans in a variant form of Ehlers-Danlos syndrome.
    Fushimi H; Kameyama M; Shinkai H
    J Intern Med; 1989 Dec; 226(6):409-16. PubMed ID: 2562251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.